The success of a building is not often measured in quantifiable terms. But when Aaron Miscenich, the executive director of the New Orleans BioInnovation Center, embarked on a new building laden with energy-intensive labs on a former brownfield site in a depopulated area of the city's downtown, he needed hard numbers to make the gamble pay off.
Begun in 2007—two years after Hurricane Katrina—the center was conceived as an incubator for biotechnology start-ups. “There was a stigma to the city,” says Mark Ripple, partner at New Orleans–based Eskew+Dumez+Ripple. “It was seen as contaminated goods, both literally and figuratively. Graduates from our universities were moving to other cities. We needed to entice the best and the brightest to stay.”
You have 0 complimentary articles remaining.
Unlimited access + premium benefits for as low as $1.99/month.